Your browser doesn't support javascript.
loading
Inhibition of the EGFR/STAT3/CEBPD Axis Reverses Cisplatin Cross-resistance with Paclitaxel in the Urothelial Carcinoma of the Urinary Bladder.
Wang, Wei-Jan; Li, Chien-Feng; Chu, Yu-Yi; Wang, Yu-Hui; Hour, Tzyh-Chyuan; Yen, Chia-Jui; Chang, Wen-Chang; Wang, Ju-Ming.
Affiliation
  • Wang WJ; Institute of Basic Medical Science, China Medical University, Taiwan R.O.C.
  • Li CF; Department of Pathology, Chi-Mei Medical Center, Tainan, Taiwan R.O.C.
  • Chu YY; Department of Biotechnology, Southern Taiwan University of Science and Technology, Tainan, Taiwan R.O.C.
  • Wang YH; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan R.O.C.
  • Hour TC; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan R.O.C.
  • Yen CJ; Institute of Bioinformatics and Biosignal Transduction, National Cheng Kung University, Tainan, Taiwan R.O.C.
  • Chang WC; Institute of Bioinformatics and Biosignal Transduction, National Cheng Kung University, Tainan, Taiwan R.O.C.
  • Wang JM; Department of Biochemistry, Kaohsiung Medical University, Kaohsiung, Taiwan R.O.C.
Clin Cancer Res ; 23(2): 503-513, 2017 Jan 15.
Article in En | MEDLINE | ID: mdl-27435393

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma / STAT3 Transcription Factor / CCAAT-Enhancer-Binding Protein-delta / ErbB Receptors Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2017 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma / STAT3 Transcription Factor / CCAAT-Enhancer-Binding Protein-delta / ErbB Receptors Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2017 Document type: Article Country of publication: United States